Donald W. DeGolyer - 12 Aug 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
12 Aug 2025
Net transactions value
-$67,831
Form type
4
Filing time
13 Aug 2025, 16:22:58 UTC
Previous filing
02 May 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DeGolyer Donald W Director 300 PROFESSIONAL DR, GAITHERSBURG /s/ Richard S. Lindahl, Attorney-in-fact 13 Aug 2025 0001583098

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale $67,831 -7,844 -5.4% $8.65 137,659 12 Aug 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the Reporting Person to satisfy the Reporting Person's tax obligations resulting from the settlement of vested RSUs on May 22, 2025.
F2 All shares sold at an exact price of $8.6475.